Clinical Trials Logo

Clinical Trial Summary

Primary Objective: Evaluation of the

- Carriage rate of Streptococcus pneumoniae in the nasopharynx of children

Secondary Objective:

- Carriage rate and distribution of Streptococcus pneumoniae serotypes

- Estimation of prevalence rate of antibiotic-resistant Streptococcus pneumoniae strains

- Distribution of Staphylococcus aureus strain

- The influence of risk factors in the Streptococcus pneumoniae carriage rate in children


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00471822
Study type Observational
Source Pfizer
Contact
Status Completed
Phase N/A
Start date July 2005
Completion date December 2010

See also
  Status Clinical Trial Phase
Completed NCT01446926 - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Phase 1
Completed NCT01444352 - Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults Phase 1
Completed NCT01444339 - Study of Two Investigational Pneumococcal Vaccines in Healthy Adults Phase 1
Completed NCT00952367 - Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China N/A